Our findings indicate that KANK1 localization at the cell-cell junction of LECs from multilayered carcinomas leads to NOS1AP binding, disassembly of the SCRIB/NOS1AP complex, which profoundly compromises SCRIB’s ability to activate the Hippo pathway and stabilizes TAZ. The gene discussed is KANK1; the disease is carcinoma.